Global Oncology Academy
Popular
Joyce O'Shaughnessy, MD
Daniel Kwon, MD
- MinuteCE®
Differentiating Safety Profiles of CDK4/6 Inhibitor Combination Regimens
1.25 program creditsHope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Medical News
- newsroom.heart.org11/20/2024
- Medical NewsMohs Surgery Matches Wide Excision in Effectiveness for Lentigo Maligna Melanoma, Study Showspracticaldermatology.com11/20/2024
- pbrc.edu11/20/2024
- emjreviews.com11/20/2024
CME/CE
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Amir T. Fathi, MD
Courtney DiNardo, MD
Brian A. Jonas, MD, PhD
Clinical Practice
- Project Oncology®
Radium-223’s Potential Quality of Life Benefits for mCRPC Patients
- MinuteCE®
Endpoints in Adjuvant Breast Cancer Trials: Implications for Clinical Practice
1.25 program creditsHope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Betsy O'Donnell, MD
Programs
- Project Oncology®
Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
Charles Turck, PharmD, BCPS, BCCCP
Hannah McManus, MD
Andrew Armstrong, MD, MSc
- Project Oncology®
Navigating mCRPC Treatment: A Look at Abiraterone and Enzalutamide
Peter Buch, MD, FACG, AGAF, FACP
William Grady, MD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD